Bio-Rad Laboratories (BIO.B) vs iRadimed (IRMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Bio-Rad Laboratories (BIO.B) has outperformed iRadimed (IRMD) over the past year, gaining 28.2% versus a gain of 11.7%. Over five years, IRMD leads with a +134.2% price change compared with -50.5% for BIO.B. Bio-Rad Laboratories is the larger company by market cap ($9.76 billion vs $1.12 billion), about 8.7 times the size.
On valuation, Bio-Rad Laboratories trades at a lower trailing P/E (46.3x vs 48.9x for iRadimed). iRadimed pays a dividend yielding 0.88%, while Bio-Rad Laboratories does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BIO.B | IRMD |
|---|---|---|
| Share price | $365.08 | $87.47 |
| Market cap | $9.76B | $1.12B |
| 1-day change | 0.00% | +1.85% |
| YTD return | +17.50% | -11.72% |
| 1-year return | +28.15% | +11.72% |
| 5-year return | -50.54% | +134.20% |
| P/E ratio (TTM) | 46.27 | 48.87 |
| Forward P/E | — | 35.65 |
| EPS (TTM) | $7.89 | $1.79 |
| Dividend yield | 0.00% | 0.88% |
| Annual dividend | $0.00 | $0.77 |
| Revenue (latest FY) | $2.58B | — |
| Revenue growth (YoY) | +0.65% | — |
| Net income (latest FY) | $759.90M | — |
| Gross margin | 51.87% | — |
| Operating margin | 1.83% | — |
| Net margin | 29.42% | — |
| 52-week high | $365.08 | $107.90 |
| 52-week low | $244.54 | $71.34 |
| Distance from 52-week high | 0.00% | -18.93% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +34.90% |
| Average volume | 6 | 125.83K |
| Shares outstanding | 5.06M | 12.79M |
| Employees | 7,450 | 166 |
| Sector | Healthcare | Health Care |
| Industry | Medical Devices | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Bio-Rad Laboratories is about 8.7 times larger than iRadimed by market value ($9.76B vs $1.12B).
- BIO.B has outperformed IRMD by 16.4 percentage points over the past year.
- The two companies sit in different sectors: Bio-Rad Laboratories in Healthcare and iRadimed in Health Care.
About Bio-Rad Laboratories
BIO.B stock →Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally.
Healthcare · Medical Devices · 7,450 employees
About iRadimed
IRMD stock →IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device.
Health Care · Medical/Dental Instruments · 166 employees
BIO.B vs IRMD FAQ
Which is bigger, Bio-Rad Laboratories or iRadimed?
Bio-Rad Laboratories (BIO.B) is larger, with a market capitalization of $9.76B compared with $1.12B for iRadimed (IRMD).
Which stock has performed better over the past year, BIO.B or IRMD?
BIO.B returned +28.15% over the past 12 months, compared with +11.72% for IRMD (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, BIO.B or IRMD?
BIO.B has the lower trailing P/E at 46.3, versus 48.9 for IRMD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Bio-Rad Laboratories or iRadimed?
iRadimed pays a dividend yielding 0.88%, while Bio-Rad Laboratories does not currently pay a regular dividend.
Are Bio-Rad Laboratories and iRadimed in the same industry?
No. Bio-Rad Laboratories is in the Healthcare sector, while iRadimed is in Health Care.